DexCom, Inc. (NASDAQ:DXCM) Q4 2020 Earnings Conference Call February 11, 2021 4:30 PM ET Company Participants Sean Christensen - Senior IR Manager Kevin Sayer - Executive Chairman, CEO & President Quentin Blackford - CFO & COO Steven Pacelli - EVP, Strategy & Corporate Development Conference Call Participants Robert Marcus - JPMorgan Chase & Co. Jeffrey Johnson - Robert W. Baird & Co. Margaret Andrew - William Blair & Company Matthew O'Brien - Piper Sandler & Co. Matthew Taylor - UBS Investment Bank Jayson ...

DexCom, Inc. (NASDAQ:DXCM) Q3 2020 Earnings Conference Call October 27, 2020 4:30 PM ET Company Participants Sean Christensen - Senior Investor Relations Manager Kevin Sayer - Chairman, President & Chief Executive Officer Quentin Blackford - Chief Operating Officer & Chief Financial Officer Steve Pacelli - Executive Vice President of Strategy & Corporate Development Conference Call Participants Robbie Marcus - JPMorgan Danielle Antalffy - SVB Leerink Matthew Blackman - Stifel Jeff Johnson - Baird Joanne Wue ...

Table of Contents Emerging Growth Company ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51222 DEXCOM, INC. (Exact name of registrant as specified in its charter) Delaware 33-0857544 ...

DexCom, Inc. (NASDAQ:DXCM) Q2 2020 Earnings Conference Call July 28, 2020 4:30 PM ET Company Participants Sean Christensen - Senior Investor Relations Manager Kevin Sayer - Chairman, President and Chief Executive Officer Quentin Blackford - Chief Operating Officer and Chief Financial Officer Steve Pacelli - Executive Vice President of Strategy and Corporate Development Conference Call Participants Jeff Johnson - Baird Kyle Rose - Canaccord Ryan Blicker - Cowen Bobby Marcus - JPMorgan Margaret Kaczor - Willi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51222 DEXCOM, INC. (Exact name of Registrant as specified in its charter) Delaware 33-0857544 (State or Other Jurisdiction of ...